CENPK Orchestrates Ovarian Cancer Progression Via GOLPH3-Mediated Activation of Mtor Signaling

Gaolian Li,Jing Shen,Wenhao Cheng,Xiaoshuo Wang,Dan Wang,Yizhuo Song,Yulu Chen,Xiuming Li,Meiqi Zhang,Yuanyuan Ding,Xinhui Ma,Qilan Qian,Geng Zhang,Jing Ji,Bin Liu
DOI: https://doi.org/10.1016/j.mce.2024.112253
IF: 4.369
2024-01-01
Molecular and Cellular Endocrinology
Abstract:Ovarian cancer stands as a formidable clinical challenge, with limited therapeutic options. This investigation delves into the intricate molecular mechanisms governing ovarian cancer progression and uncovers Centromere Protein K (CENPK) as a central figure in disease pathogenesis. Elevated CENPK levels within ovarian cancer tissues conspicuously align with adverse clinical outcomes, positioning CENPK as a promising prognostic biomarker. Deeper exploration reveals a direct transcriptional connection between CENPK and the E2F1 transcription factor and clearly establishes E2F1’s role as the master regulator of CENPK expression in ovarian cancer. Our inquiry revealing a suppression of tumor-promoting signaling pathways, most notably the mTOR pathway, upon CENPK silencing. Intriguingly, CENPK renders ovarian cancer cells more responsive to the mTOR inhibitor rapamycin, introducing a promising avenue for therapeutic intervention. In summation, our study unravels the multifaceted role of CENPK in ovarian cancer progression. It emerges as a prognostic indicator, a pivotal mediator of cell proliferation and tumorigenicity, and a regulator of the mTOR pathway, shedding light on potential therapeutic avenues for this formidable disease.
What problem does this paper attempt to address?